HAP Trading’s Filana Therapeutics FLNA Stock Holding History

HAP Trading’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13,848	Closed	-$726K	–	2816
2021 Q3	$860K	Buy	13,848 +3,422	+33%	+$286K	0.03%	509
2021 Q2	$891K	Buy	+10,426	New	+$558K	0.03%	491

Other funds holding FLNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

HAP Trading's FLNA Position: Q4 2021 in Review

HAP Trading sold out of Filana Therapeutics (FLNA) in Q4 2021, closing a stake of 13,848 shares — an estimated $726K sold.

HAP Trading first reported a position in FLNA in Q2 2021 and held it in 2 quarters. The position peaked at $891K in Q2 2021. 171 funds tracked by Wall St. Rank hold FLNA as of Q4 2021.

HAP Trading reported no remaining Filana Therapeutics position as of Q4 2021 after selling out during the quarter.
HAP Trading sold 13,848 Filana Therapeutics shares in Q4 2021, an estimated $726K.
HAP Trading first reported a position in Filana Therapeutics in Q2 2021 and held it in 2 quarters.
HAP Trading's Filana Therapeutics position peaked at $891K in Q2 2021.
171 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.